These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 29320563)

  • 1. Field effectiveness of highly pathogenic avian influenza H5N1 vaccination in commercial layers in Indonesia.
    Tarigan S; Wibowo MH; Indriani R; Sumarningsih S; Artanto S; Idris S; Durr PA; Asmara W; Ebrahimie E; Stevenson MA; Ignjatovic J
    PLoS One; 2018; 13(1):e0190947. PubMed ID: 29320563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of M2e ELISAs for longitudinal surveillance of commercial poultry in Indonesia vaccinated against highly pathogenic avian influenza.
    Wibowo MH; Tarigan S; Sumarningsih ; Artanto S; Indriani R; Anggoro D; Putra CP; Idris S; Untari T; Asmara W; Tabbu CR; Ignjatovic J
    J Virol Methods; 2017 Nov; 249():181-188. PubMed ID: 28843786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a conserved HA274-288 epitope to detect antibodies to highly pathogenic avian influenza virus H5N1 in Indonesian commercial poultry.
    Wawegama NK; Tarigan S; Indriani R; Selleck P; Adjid RA; Syafriati T; Hardiman ; Durr PA; Ignjatovic J
    Avian Pathol; 2016 Aug; 45(4):478-92. PubMed ID: 27009612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silent spread of highly pathogenic Avian Influenza H5N1 virus amongst vaccinated commercial layers.
    Poetri ON; Van Boven M; Claassen I; Koch G; Wibawan IW; Stegeman A; Van den Broek J; Bouma A
    Res Vet Sci; 2014 Dec; 97(3):637-41. PubMed ID: 25301756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody titer has positive predictive value for vaccine protection against challenge with natural antigenic-drift variants of H5N1 high-pathogenicity avian influenza viruses from Indonesia.
    Swayne DE; Suarez DL; Spackman E; Jadhao S; Dauphin G; Kim-Torchetti M; McGrane J; Weaver J; Daniels P; Wong F; Selleck P; Wiyono A; Indriani R; Yupiana Y; Sawitri Siregar E; Prajitno T; Smith D; Fouchier R
    J Virol; 2015 Apr; 89(7):3746-62. PubMed ID: 25609805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the effectiveness of rHVT-H5, inactivated H5 and rHVT-H5 with inactivated H5 prime/boost vaccination regimes in commercial broiler chickens carrying MDAs against HPAI H5N1 clade 2.2.1 virus.
    Kilany WH; Hassan MK; Safwat M; Mohammed S; Selim A; VonDobschuetz S; Dauphin G; Lubroth J; Jobre Y
    Avian Pathol; 2015 Oct; 44(5):333-41. PubMed ID: 26023824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single vaccination of commercial broilers does not reduce transmission of H5N1 highly pathogenic avian influenza.
    Poetri O; Bouma A; Claassen I; Koch G; Soejoedono R; Stegeman A; van Boven M
    Vet Res; 2011 Jun; 42(1):74. PubMed ID: 21635732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental challenge of chicken vaccinated with commercially available H5 vaccines reveals loss of protection to some highly pathogenic avian influenza H5N1 strains circulating in Hong Kong/China.
    Connie Leung YH; Luk G; Sia SF; Wu YO; Ho CK; Chow KC; Tang SC; Guan Y; Malik Peiris JS
    Vaccine; 2013 Aug; 31(35):3536-42. PubMed ID: 23791547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Field trial for assessment of avian influenza vaccination effectiveness in Indonesia.
    Bouma A; Muljono AT; Jatikusumah A; Nell AJ; Mudjiartiningsih S; Dharmayanti I; Siregar ES; Claassen I; Koch G; Stegeman JA
    Rev Sci Tech; 2008 Dec; 27(3):633-42. PubMed ID: 19284033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the M2e antibody response following highly pathogenic H5N1 avian influenza virus infection and reliability of M2e ELISA for identifying infected among vaccinated chickens.
    Tarigan S; Indriani R; Durr PA; Ignjatovic J
    Avian Pathol; 2015; 44(4):259-68. PubMed ID: 25915110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective efficacy of crude virus-like particle vaccine against HPAI H5N1 in chickens and its application on DIVA strategy.
    Park JK; Lee DH; Youn HN; Kim MS; Lee YN; Yuk SS; Lim TH; Jang JH; Kwon JH; Kim BY; Kang SM; Seong BL; Lee JB; Park SY; Choi IS; Song CS
    Influenza Other Respir Viruses; 2013 May; 7(3):340-8. PubMed ID: 22716302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple dose vaccination with heterologous H5N2 vaccine: immune response and protection against variant clade 2.2.1 highly pathogenic avian influenza H5N1 in broiler breeder chickens.
    Abdelwhab EM; Grund C; Aly MM; Beer M; Harder TC; Hafez HM
    Vaccine; 2011 Aug; 29(37):6219-25. PubMed ID: 21745517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. H5-based DNA constructs derived from selected highly pathogenic H5N1 avian influenza virus induce high levels of humoral antibodies in Muscovy ducks against low pathogenic viruses.
    Guionie O; Niqueux E; Amelot M; Bougeard S; Jestin V
    Virol J; 2014 Apr; 11():74. PubMed ID: 24762011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highly pathogenic avian influenza virus H5N1 from Egypt escapes vaccine-induced immunity but confers clinical protection against a heterologous clade 2.2.1 Egyptian isolate.
    Grund C; Abdelwhab el-SM; Arafa AS; Ziller M; Hassan MK; Aly MM; Hafez HM; Harder TC; Beer M
    Vaccine; 2011 Jul; 29(33):5567-73. PubMed ID: 21244859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly pathogenic avian influenza (H5N1) in ducks and in-contact chickens in backyard and smallholder commercial duck farms in Viet Nam.
    Henning J; Henning KA; Morton JM; Long NT; Ha NT; Vu le T; Vu PP; Hoa DM; Meers J
    Prev Vet Med; 2011 Sep; 101(3-4):229-40. PubMed ID: 20594603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-Protection by Inactivated H5 Prepandemic Vaccine Seed Strains against Diverse Goose/Guangdong Lineage H5N1 Highly Pathogenic Avian Influenza Viruses.
    Criado MF; Sá E Silva M; Lee DH; Salge CAL; Spackman E; Donis R; Wan XF; Swayne DE
    J Virol; 2020 Nov; 94(24):. PubMed ID: 32999029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental and Field Results Regarding Immunity Induced by a Recombinant Turkey Herpesvirus H5 Vector Vaccine Against H5N1 and Other H5 Highly Pathogenic Avian Influenza Virus Challenges.
    Gardin Y; Palya V; Dorsey KM; El-Attrache J; Bonfante F; Wit Sd; Kapczynski D; Kilany WH; Rauw F; Steensels M; Soejoedono RD
    Avian Dis; 2016 May; 60(1 Suppl):232-7. PubMed ID: 27309060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long lasting immunity in chickens induced by a single shot of influenza vaccine prepared from inactivated non-pathogenic H5N1 virus particles against challenge with a highly pathogenic avian influenza virus.
    Sasaki T; Kokumai N; Ohgitani T; Sakamoto R; Takikawa N; Lin Z; Okamatsu M; Sakoda Y; Kida H
    Vaccine; 2009 Aug; 27(38):5174-7. PubMed ID: 19596414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccine Protection of Turkeys Against H5N1 Highly Pathogenic Avian Influenza Virus with a Recombinant Turkey Herpesvirus Expressing the Hemagglutinin Gene of Avian Influenza.
    Kapczynski DR; Dorsey K; Chrzastek K; Moraes M; Jackwood M; Hilt D; Gardin Y
    Avian Dis; 2016 Jun; 60(2):413-7. PubMed ID: 27309280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective Efficacy of Recombinant Turkey Herpes Virus (rHVT-H5) and Inactivated H5N1 Vaccines in Commercial Mulard Ducks against the Highly Pathogenic Avian Influenza (HPAI) H5N1 Clade 2.2.1 Virus.
    Kilany WH; Safwat M; Mohammed SM; Salim A; Fasina FO; Fasanmi OG; Shalaby AG; Dauphin G; Hassan MK; Lubroth J; Jobre YM
    PLoS One; 2016; 11(6):e0156747. PubMed ID: 27304069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.